Chronic CED of TPT for Recurrent Malignant Glioma
Abroad (travel likely)RecruitingPHASE1
Conditions
Brain Tumor, Recurrent · Malignant Glioma (WHO Grade III or IV) · IDH1/IDH2 Mutation
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York, New York, United States
Contact: Study coordinator (Research Nurse Navigator) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162Contact: Principal Investigator (Jeffrey Bruce, MD)
Study leads
Jeffrey Bruce, MD
Principal Investigator
Columbia University